2. Gene
  3. MEF2A - myocyte enhancer factor 2A Gene

MEF2A - myocyte enhancer factor 2A Gene

  • Gene
  • Protein
  • Disease
  • Agent
  • Ortholog
Homo sapiens

Also known as mef2; ADCAD1; RSRFC4; RSRFC9

Gene ID: 4205 | Gene type: protein coding

About MEF2A

Cytogenetic location: 15q26.3 Genomic coordinates (GRCh38): 15:99,565,417-99,716,488 (from NCBI)

This gene has 18 transcripts (splice variants), 203 orthologues, 4 paralogues and is associated with 2 phenotypes. Ubiquitous expression in heart (RPKM 14.6), brain (RPKM 12.2) and 25 other tissues.

Summary

The protein encoded by this gene is a DNA-binding transcription factor that activates many muscle-specific, growth factor-induced, and stress-induced genes. The encoded protein can act as a homodimer or as a heterodimer and is involved in several cellular processes, including muscle development, neuronal differentiation, cell growth control, and Apoptosis. Defects in this gene could be a cause of autosomal dominant coronary artery disease 1 with myocardial infarction (ADCAD1). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]

MEF2A Products(62)

mRNA Protein Name
NM_001130926.5 NP_001124398.1 myocyte-specific enhancer factor 2A isoform 2
NM_001130927.5 NP_001124399.1 myocyte-specific enhancer factor 2A isoform 3
NM_001130928.4 NP_001124400.1 myocyte-specific enhancer factor 2A isoform 4
NM_001171894.5 NP_001165365.1 myocyte-specific enhancer factor 2A isoform 2
NM_001319206.4 NP_001306135.1 myocyte-specific enhancer factor 2A isoform 5
NM_001352614.4 NP_001339543.1 myocyte-specific enhancer factor 2A isoform 2
NM_001352615.4 NP_001339544.1 myocyte-specific enhancer factor 2A isoform 2
NM_001352616.4 NP_001339545.1 myocyte-specific enhancer factor 2A isoform 5
NM_001352617.4 NP_001339546.1 myocyte-specific enhancer factor 2A isoform 1
NM_001352618.4 NP_001339547.1 myocyte-specific enhancer factor 2A isoform 6
NM_001365201.3 NP_001352130.1 myocyte-specific enhancer factor 2A isoform 7
NM_001365202.3 NP_001352131.1 myocyte-specific enhancer factor 2A isoform 7
NM_001365203.3 NP_001352132.1 myocyte-specific enhancer factor 2A isoform 8
NM_001365204.3 NP_001352133.1 myocyte-specific enhancer factor 2A isoform 8
NM_001365205.3 NP_001352134.1 myocyte-specific enhancer factor 2A isoform 5
NM_001365206.3 NP_001352135.1 myocyte-specific enhancer factor 2A isoform 6
NM_001365207.3 NP_001352136.1 myocyte-specific enhancer factor 2A isoform 1
NM_001365208.3 NP_001352137.1 myocyte-specific enhancer factor 2A isoform 2
NM_001365209.3 NP_001352138.1 myocyte-specific enhancer factor 2A isoform 3
NM_001365210.2 NP_001352139.1 myocyte-specific enhancer factor 2A isoform 10
NM_001365211.2 NP_001352140.1 myocyte-specific enhancer factor 2A isoform 11
NM_001393558.2 NP_001380487.1 myocyte-specific enhancer factor 2A isoform 12
NM_001393559.2 NP_001380488.1 myocyte-specific enhancer factor 2A isoform 4
NM_001393560.2 NP_001380489.1 myocyte-specific enhancer factor 2A isoform 13
NM_001393561.3 NP_001380490.1 myocyte-specific enhancer factor 2A isoform 14
NM_001400028.1 NP_001386957.1 myocyte-specific enhancer factor 2A isoform 15
NM_001400029.1 NP_001386958.1 myocyte-specific enhancer factor 2A isoform 8
NM_001400030.1 NP_001386959.1 myocyte-specific enhancer factor 2A isoform 8
NM_001400031.1 NP_001386960.1 myocyte-specific enhancer factor 2A isoform 5
NM_001400032.1 NP_001386961.1 myocyte-specific enhancer factor 2A isoform 5
NM_001400033.1 NP_001386962.1 myocyte-specific enhancer factor 2A isoform 5
NM_001400034.1 NP_001386963.1 myocyte-specific enhancer factor 2A isoform 5
NM_001400035.1 NP_001386964.1 myocyte-specific enhancer factor 2A isoform 5
NM_001400036.1 NP_001386965.1 myocyte-specific enhancer factor 2A isoform 5
NM_001400037.1 NP_001386966.1 myocyte-specific enhancer factor 2A isoform 6
NM_001400038.1 NP_001386967.1 myocyte-specific enhancer factor 2A isoform 1
NM_001400039.1 NP_001386968.1 myocyte-specific enhancer factor 2A isoform 1
NM_001400040.1 NP_001386969.1 myocyte-specific enhancer factor 2A isoform 1
NM_001400049.1 NP_001386978.1 myocyte-specific enhancer factor 2A isoform 1
NM_001400050.1 NP_001386979.1 myocyte-specific enhancer factor 2A isoform 1
NM_001400051.1 NP_001386980.1 myocyte-specific enhancer factor 2A isoform 1
NM_001400052.1 NP_001386981.1 myocyte-specific enhancer factor 2A isoform 1
NM_001400053.1 NP_001386982.1 myocyte-specific enhancer factor 2A isoform 1
NM_001400054.1 NP_001386983.1 myocyte-specific enhancer factor 2A isoform 2
NM_001400055.1 NP_001386984.1 myocyte-specific enhancer factor 2A isoform 2
NM_001400056.1 NP_001386985.1 myocyte-specific enhancer factor 2A isoform 2
NM_001400057.1 NP_001386986.1 myocyte-specific enhancer factor 2A isoform 2
NM_001400058.1 NP_001386987.1 myocyte-specific enhancer factor 2A isoform 2
NM_001400059.1 NP_001386988.1 myocyte-specific enhancer factor 2A isoform 2
NM_001400060.1 NP_001386989.1 myocyte-specific enhancer factor 2A isoform 2
NM_001400061.1 NP_001386990.1 myocyte-specific enhancer factor 2A isoform 2
NM_001400062.1 NP_001386991.1 myocyte-specific enhancer factor 2A isoform 2
NM_001400063.1 NP_001386992.1 myocyte-specific enhancer factor 2A isoform 2
NM_001400064.1 NP_001386993.1 myocyte-specific enhancer factor 2A isoform 2
NM_001400065.1 NP_001386994.1 myocyte-specific enhancer factor 2A isoform 2
NM_001400066.1 NP_001386995.1 myocyte-specific enhancer factor 2A isoform 2
NM_001400067.1 NP_001386996.1 myocyte-specific enhancer factor 2A isoform 16
NM_001400068.1 NP_001386997.1 myocyte-specific enhancer factor 2A isoform 12
NM_001400069.1 NP_001386998.1 myocyte-specific enhancer factor 2A isoform 17
NM_001400070.1 NP_001386999.1 myocyte-specific enhancer factor 2A isoform 11
NM_001400071.1 NP_001387000.1 myocyte-specific enhancer factor 2A isoform 11
NM_005587.6 NP_005578.2 myocyte-specific enhancer factor 2A isoform 1

MEF2A Protein Structure

SRF-TF

SRF-TF: SRF-type transcription factor (DNA-binding and dimerisation domain) (10 - 59)

HJURP_C

HJURP_C: Holliday junction regulator protein family C-terminal repeat (90 - 154)

  • 0
  • 100
  • 200
  • 300
  • 400
  • 499 a.a.
Protein Preferred Names Protein Names

myocyte-specific enhancer factor 2A

MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A)

Related Diseases

Diseases Alias
Coronary Artery Disease, Autosomal Dominant, 1

ADCAD1

Coronary Artery Disease With Myocardial Infarction

Coronary Artery Disease/Myocardial Infarction

Artery, Coronary, Disease, Autosomal Dominant, Type 1
Myocardial Infarction

Heart Attack

Myocardial Infarction, Susceptibility To

Myocardial Infarction 1

Myocardial Infarction, Protection Against

Myocardial Infarction, Decreased Susceptibility To

Myocardial Infarction, Decreased

Myocardial Infarct

MCI1

Premature Myocardial Infarction

Myocardial Infarction, Susceptibility To, Type 1
Muscle Hypertrophy

MSLHP

Hypertrophy

Hypertrophy, Muscle
Heart Disease

Heart Failure

Congenital Heart Disease

Heart Diseases

Congenital Heart Defects

Congenital Heart Defect

Heart Malformation

Congenital Anomaly Of Heart

Heart Defect

Heart-Congenital Defect

Congenital Heart Disorder

Heart Defects Congenital

Heart Defects, Congenital

Heart Defects

Heart Disease, Congenital

Disease, Heart, Congenital

Congestive Heart Failure
Ichthyosis, Congenital, Autosomal Recessive 9

Autosomal Recessive Congenital Ichthyosis 9

ARCI9

Ichthyosis, Congenital, Autosomal Recessive, Type 9
Brachydactyly, Type E1

Brachydactyly Type E1

Brachydactyly Type E

BDE1

Brachydactyly, Type E

Bde

Type E Brachydactyly

Brachydactyly E1

Brachydactyly Syndrome Type E
Lipoprotein Quantitative Trait Locus

Coronary Artery Disease

Coronary Artery Anomaly

Coronary Artery Disease, Susceptibility To

Myocardial Ischemia

Congenital Anomaly Of Coronary Artery

Coronary Arteriosclerosis

Coronary Disease

Coronary Heart Disease

Coronary Artery Disorder

LPAQTL

Lpa Deficiency, Congenital

Coronary Artery Abnormality

Coronary Artery Anomaly, Congenital

Chd

Coronary Syndrome

Congenital Malformations Of Coronary Vessels

Malformation Of Coronary Vessels

Congenital Coronary Artery Anomaly

Congenital Coronary Artery Deformity

Congenital Coronary Artery Disorder

Abnormal Coronary Artery

Congenital Coronary Artery Malposition

Congenital Coronary Disease

Congenital Anomaly Of Coronary Arteries
Rhabdomyosarcoma
Microphthalmia

Microphthalmos

Isolated Anophthalmia-Microphthalmia Syndrome

Isolated Microphthalmia-Anophthalmia-Coloboma

Simple Microphthalmos

Clinical Anophthalmia

Isolated Anophthalmia - Microphthalmia

Isolated Pure Microphthalmia

Mac Spectrum

Microphthalmia-Anophthalmia-Coloboma Spectrum

Primitive Anophthalmia

Globe Of Eye Small

Small Eyeball

Hypoplasia Of Eye

Isolated Nanophthalmos

Rudimentary Eye

Dysplasia Of Eye
Dilated Cardiomyopathy

Familial Dilated Cardiomyopathy

Primary Dilated Cardiomyopathy

Idiopathic Dilated Cardiomyopathy

Congestive Cardiomyopathy

Idiopathic Dilation Cardiomyopathy

Primary Familial Dilated Cardiomyopathy

Cardiomyopathy, Dilated

DCM

Cardiomyopathy, Familial Dilated

Dilated Cardiomyopathy, Familial

Hypokinetic Dilated Cardiomyopathy, Familial

Familial Idiopathic Cardiomyopathy

Fdc

Cardiomyopathy, Familial Idiopathic

Idiopathic Cardiomegaly

Dilated Congestive Cardiomyopathy

Chronic Dilated Cardiomyopathy

Ccm - [Congestive Cardiomyopathy]

Cocm - [Congestive Cardiomyopathy]

Dcm - [Dilated Cardiomyopathy]

Dilated-Hypokinetic Cardiomyopathy

Congestive Idiopathic Cardiomyopathy

Primary Idiopathic Dilated Cardiomyopathy
Hypertrophic Cardiomyopathy

Hypertrophic Obstructive Cardiomyopathy

Cardiomyopathy, Hypertrophic

Cardiomyopathy Hypertrophic Obstructive

Cardiomyopathy, Hypertrophic, Familial

Idiopathic Myocardial Hypertrophy

Idiopathic Hypertrophic Cardiomyopathy

Obstructive Idiopathic Hypertrophic Cardiomyopathy

Obstructive Cardiomyopathy

Idiopathic Hypertrophic Subaortic Stenosis

Muscular Subaortic Stenosis

Hypertrophic Obstructive Subaortic Stenosis
Type 2 Diabetes Mellitus

Insulin Resistance

NIDDM

Type 2 Diabetes

Diabetes Mellitus, Non-Insulin-Dependent

T2D

Noninsulin-Dependent Diabetes Mellitus

Diabetes Mellitus, Type Ii

Maturity-Onset Diabetes

Insulin Resistance, Severe, Digenic

Diabetes Mellitus, Type 2

Diabetes Mellitus, Noninsulin-Dependent

Diabetes Mellitus, Noninsulin-Dependent, Association With

Diabetes Mellitus, Noninsulin-Dependent, Late Onset

Hypertension, Insulin Resistance-Related, Susceptibility To

Insulin Resistance, Susceptibility To

Non-Insulin-Dependent Diabetes Mellitus

Type Ii Diabetes Mellitus

Adult-Onset Diabetes Mellitus

Maturity-Onset Diabetes Mellitus

Diabetes Mellitus Type 2

Type Ii Diabetes

Type 2 Diabetes Mellitus, Susceptibility To

Diabetes, Type 2

Diabetes Mellitus, Noninsulin-Dependent, Susceptibility To

Diabetes Mellitus, Non-Insulin-Dependent, Susceptibility To

Diabetes Mellitus, Type 2, Susceptibility To

Diabetes Mellitus, Noninsulin-Dependent, 2

Diabetes Mellitus, Type Ii, Susceptibility To

Hypertension, Insulin Resistance-Related

Adult-Onset Diabetes

Aodm

Diabetes Mellitus, Adult-Onset

Diabetes Mellitus Type Ii

Diabetes Mellitus Type 2, Susceptibility To

Diabetes, Type Ii, Susceptibility To

Diabetes Type 2

Diabetes Mellitus

Adult Onset Diabetes

Maturity Onset Diabetes

Nonketotic Diabetes

Non-Insulin Dependent Diabetes Mellitus

T2dm - [Type 2 Diabetes Mellitus]

Niddm - [Non Insulin Dependent Diabetes Mellitus]

Dm2

Dm Type Ii

Diabetic Type 2

Insulin Requiring Type 2 Diabetes

Noninsulin Dependent Diabetes

Non-Insulin-Dependent Diabetes Mellitus Without Complications

Diabetes Due To Insulin Secretory Defect

Diabetes Mellitus Due To Insulin Secretory Defect

Non-Insulin-Dependent Diabetes Of The Young

Senile Diabetes

Nonketotic Hyperglycaemia

Stable Diabetes
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

Pre-clinical Phase
Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-RS08309 MEF2A Human Pre-designed siRNA Set A Pre-designed Sets / Unkown

Orthologs Information

Species Symbol Source ID
Bos taurus MEF2A VGNC VGNC:31372
Mus musculus MEF2A MGD MGI:99532
Felis catus MEF2A VGNC VGNC:68229
Macaca mulatta MEF2A VGNC VGNC:74698
Rattus norvegicus MEF2A RGD RGD:1359360
Canis familiaris MEF2A VGNC VGNC:43143